No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain

We aimed to determine the reversibility of ≥7% weight gain (WG) within 12 months following TAF- and/or INSTI-discontinuation in people with HIV (PWH) from the Dutch ATHENA cohort. PWH with ≥7% WG within 24 months after first switch to TAF and/or INSTI whilst being virally suppressed were selected, e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	AIDS (London) 2023-10, Vol.37 (12), p.1843-1850
Hauptverfasser:	Verburgh, Myrthe L., Wit, Ferdinand W.N.M., Boyd, Anders, Reiss, Peter, Van der Valk, Marc
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Science: Concise Communications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!